The 2025 American Society of Hematology Annual Meeting in December in Orlando, Florida was filled with momentum, discovery ...

The HealthWell Foundation funded Brukinsa (zanubrutinib) for Mike, enabling him to afford the treatment and maintain his ...

Cognitive dysfunction in kidney cancer survivors is linked to treatment burden, stress, and fatigue, affecting daily ...

Trodelvy showed fewer severe side effects, such as neutropenia and diarrhea, compared to chemotherapy in untreated TNBC ...

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase ...

A cancer diagnosis profoundly alters family dynamics, emphasizing the importance of cherishing present moments and creating ...

And unfortunately, not everybody has as much of a village, but people tend to rally around somebody when they're going through cancer, especially because they know somebody who's gone through it, or ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

AstraZeneca and Daiichi Sankyo’s Enhertu's breakthrough therapy designation as a post-neoadjuvant treatment option for ...

Common symptoms that palliative care teams see in patients with metastatic breast cancer include pain, menopausal symptoms, ...

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...

Dr. Vikram Gorantla explains to CURE that staying healthy and managing side effects helps patients with brain metastases ...